No Data
No Data
H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $105
Praxis Precision Med Price Target Maintained With a $105.00/Share by HC Wainwright & Co.
Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270
Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $85
EMERGN INTRODUCES PRAXIS BUSINESS & ENTERPRISE: THE GOLD STANDARD FOR PRODUCT MANAGEMENT EXCELLENCE
Praxis Precision Medicines to Hold Virtual Investor Event to Discuss Clinical Programs in Developmental and Epileptic Encephalopathies